1. Migräne allgemein

Arruda MA, Guidetti V, Galli F, Albuquerque RC, Bigal ME. Primary headaches in childhood – a population-based study. Cephalalgia 2010; 30: 1056-1064.

Diener HC, Silberstein SD. Medication overuse headache. In: Olesen J, Goadsby PJ, Ramadan NM, Tfelt-Hansen P, Welch KM (eds). The Headaches, 3rd ed. Philadelphia: Lippincott Williams & Wilkins 2006; 971-979.

GBD 2015 Disease and Injury Incidence and Prevalence Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet 2016; 388: 1545–1602.

Gelfand AA, Fullerton HJ, Goadsby PJ. Child neurology: migraine with aura in children. Neurology 2010; 75(5): e16-e19.

Goadsby PJ. Recent advances in the diagnosis and management of migraine. BMJ 2006; 332: 25-29.

Goadsby PJ. Migraine pathophysiology. Headache 2005; 45 Suppl 1: S14-S24.

Katsarava Z, Manack A, Yoon MS, Obermann M, Becker H, Dommes P, et al. Chronic migraine: classification and comparisons. Cephalalgia 2011; 31: 520-529.

Lipton RB, Bigal ME, Steiner TJ, Silberstein SD, Olesen J. Classification of primary headaches. Neurology 2004; 63: 427-435.

Martelletti P, Haimanot RT, Lainez MJ, Rapoport AM, Ravishankar K, Sakai F, Silberstein SD, Vincent M, Steiner TJ. The Global Campaign (GC) to Reduce the Burden of Headache Worldwide. The International Team for Specialist Education (ITSE). J Headache Pain 2005; 6: 261-263.

Silberstein SD. Migraine. Lancet 2004; 363: 381-391.

Vetvik KG, Macgregor EA, Lundqvist C, Russell MB. Prevalence of menstrual migraine: a population-based study. Cephalalgia 2014; 34: 280-288.

Vetvik KG, Benth JŠ, MacGregor EA, Lundqvist C, Russell MB. Menstrual versus non-menstrual attacks of migraine without aura in women with and without menstrual migraine. Cephalalgia 2015; 35: 1261-1268.

Vos T, Flaxman AD, Naghavi M, Lozano R, Michaud C, Ezzati M et al. Years lived with disability (YLD) for 1160 sequelae of 289 diseases and injuries 1990–2010: a systematic analysis for the global burden of disease study 2010. Lancet 2012; 380: 2163-2196.

1.2 Migräne mit Aura

Cao Y, Welch KM, Aurora S, et al. Functional MRI-BOLD of visually triggered headache in patients with migraine. Arch Neurol 1999; 56: 548-554.

Charles A, Brennan K. Cortical spreading depression – new insights and persistent questions. Cephalalgia 2009; 29: 1115-1124.

Cologno D, Torelli P, Manzoni GC. Migraine with aura: a review of 81 patients at 10-20 years’ follow-up. Cephalalgia 1998; 18: 690-696.

Cutrer FM, Sorensen AG, Weisskoff RM, et al. Perfusion-weighted imaging defects during spontaneous migrainous aura. Ann Neurol 1998; 43: 25-31.

Eriksen MK, Thomsen LL, Andersen I, et al. Clinical characteristics of 362 patients with familial migraine with aura. Cephalalgia 2004; 24: 564-575.

Eriksen MK, Thomsen LL, Olesen J. The Visual Aura Rating Scale (VARS) for migraine aura diagnosis. Cephalalgia 2005; 25: 801-810.

Giffin NJ, Lipton RB, Silberstein SD, Olesen J, Goadsby PJ. The migraine postdrome: An electronic diary study. Neurology 2016; 87: 309-313.

Hadjikhani N, Sanchez del Rio M, Wu O, et al. Mechanisms of migraine aura revealed by functional MRI in human visual cortex. PNAS 2001; 98: 4687-4692.

Hansen JM, Lipton R, Dodick D, et al. Migraine headache is present in the aura phase – a prospective study. Neurology 2012; 79: 2044-2049.

Jensen K, Tfelt-Hansen P, Lauritzen M, et al. Classic migraine. A prospective recording of symptoms. Acta Neurol Scand 1986; 73: 359-362.

Kallela M, Wessman M, Farkkila M, et al. Clinical characteristics of migraine in a population-based twin sample: similarities and differences between migraine with and without aura. Cephalalgia 1999; 19: 151-158.

Kelman L. The premonitory symptoms (prodrome): A tertiary care study of 893 migraineurs. Headache 2004; 44: 865-872.

Lauritzen M. Pathophysiology of the migraine aura. The spreading depression theory. Brain 1994; 117 (Pt 1): 199-210.

Leao AAP. Spreading depression of activity in the cerebral cortex. J Neurophysiol 1944; 7: 359-390.

Lebedeva ER, Gurary NM, Gilev DV, Olesen J. Prospective testing of ICHD-3 beta diagnostic criteria for migraine with aura and migraine with typical aura in patients with transient ischemic attacks. Cephalalgia 2018; 38: 561-567.

Li D, Christensen AF, Olesen J. Field-testing of the ICHD-3  beta/proposed  ICD-11 diagnostic criteria for migraine with aura. Cephalalgia 2015; 35: 748-756.

Olesen J, Friberg L, Olsen TS, et al. Timing and topography of cerebral blood flow, aura, and headache during migraine attacks. Ann Neurol 1990; 28: 791-798.

Queiroz LP, Friedman DI, Rapoport AM, et al. Characteristics of migraine visual aura in Southern Brazil and Northern USA. Cephalalgia 2011; 31: 1652-1658.

Rasmussen BK, Olesen J. Migraine with aura and migraine without aura: an epidemiological study. Cephalalgia 1992; 12: 221-228 (discussion 186).

Salhofer-Polanyi S, Frantal S, Brannath W, et al. Prospective analysis of factors related to migraine aura – The PAMINA Study. Headache 2012; 52: 1236-1245.

Schoonman GG, Evers DJ, Terwindt GM, et al. The prevalence of premonitory symptoms in migraine: a questionnaire study in 461 patients. Cephalalgia 2006; 26: 1209-1213.

Ulrich V, Gervil M, Kyvik KO, et al. Evidence of a genetic factor in migraine with aura: A population-based Danish twin study. Ann Neurol 1999; 45: 242-246.

1.2.1 Migräne mit typischer Aura

Eriksen MK, Thomsen LL, Olesen J. Implications of clinical subtypes of migraine with aura. Headache 2006; 46: 286-297.

Hansen JM, Goadsby PJ, Charles AC. Variability of clinical features in attacks of migraine with aura. Cephalalgia 2016; 36: 216-224.

Matharu MJ, Goadsby PJ. Post-traumatic chronic paroxysmal hemicrania (CPH) with aura. Neurology 2001; 56: 273-275.

Morrison DP. Abnormal perceptual experiences in migraine. Cephalalgia 1990; 10: 273-277.
Silberstein SD, Niknam R, Rozen TD, et al. Cluster headache with aura. Neurology 2000; 54: 219-221.

Viana M, Linde M, Sances G, Ghiotto N, Guaschino E, Allena M, Terrazzino S, Nappi G, Goadsby PJ, Tassorelli C. Migraine aura symptoms: duration, succession and temporal relationship to headache. Cephalalgia 2016; 36: 413-421.

Wijman CA, Wolf PA, Kase CS, et al. Migrainous visual accompaniments are not rare in late life: the Framingham Study. Stroke 1998; 29: 1539-1543.

1.2.2 Migräne mit Hirnstammaura

Ambrosini A, D’Onofrio M, Grieco GS, et al. Familial basilar migraine associated with a new mutation in the ATP1A2 gene. Neurology 2005; 65: 1826-1828.

Bickerstaff ER. Basilar artery migraine. Lancet 1961; i: 15.

Caplan LR. Migraine and vertebrobasilar ischemia. Neurology 1991; 41: 55-61.

Eriksen MK, Thomsen LL, Olesen J. Implications of clinical subtypes of migraine with aura. Headache 2006; 46: 286-297.

Kirchmann M, Thomsen LL, Olesen J. Basilar-type migraine: clinical, epidemiologic, and genetic features. Neurology 2006; 66: 880-886.

Lempert T, Neuhauser H, Daroff RB. Vertigo as a symptom of migraine. Ann NY Acad Sci 2009; 1164: 242-251.

Li D, Christensen AF, Olesen J. Field-testing of the ICHD-3 beta/proposed  ICD-11 diagnostic criteria for migraine with aura. Cephalalgia 2015; 35: 748-756.

Sturzenegger MH, Meienberg O. Basilar artery migraine: a follow-up study of 82 cases. Headache 1985; 25: 408-415.

Swanson JW, Vick NA. Basilar artery migraine 12 patients, with an attack recorded electroencephalographically. Neurology 1978; 28: 782-786.

Thomsen LL, Eriksen MK, Roemer SF, et al. A population-based study of familial hemiplegic migraine suggests revised diagnostic criteria. Brain 2002; 125: 1379-1391.

Thomsen LL, Ostergaard E, Olesen J, et al. Evidence for a separate type of migraine with aura: sporadic hemiplegic migraine. Neurology 2003; 60: 595-601.

1.2.3 Hemiplegische Migräne

Ambrosini A, D’Onofrio M, Grieco GS, et al. Familial basilar migraine associated with a new mutation in the ATP1A2 gene. Neurology 2005; 65: 1826-1828.

De Fusco M, Marconi R, Silvestri L, et al. Haploinsufficiency of ATP1A2 encoding the Na+/K+ pump alpha2 subunit associated with familial hemiplegic migraine type 2. Nat Genet 2003; 33: 192-196.

de Vries B, Frants RR, Ferrari M, et al. Molecular genetics of migraine. Human Genet 2009; 126: 115-132.

Dichgans M, Freilinger T, Eckstein G, et al. Mutation in the neuronal voltage-gated sodium channel SCN1A in familial hemiplegic migraine. Lancet 2005; 366: 371-377.

Dreier JP, Jurkat-Rott K, Petzold GC, et al. Opening of the blood-brain barrier preceding cortical edema in a severe attack of FHM type II. Neurology 2005; 64: 2145-2147.

Eriksen MK, Thomsen LL, Olesen J. Implications of clinical subtypes of migraine with aura. Headache 2006; 46: 286-297.

Hansen JM, Schytz HW, Larsen VA, et al. Hemiplegic migraine aura begins with cerebral hypoperfusion: imaging in the acute phase. Headache 2011; 51: 1289-1296.

Hansen JM, Thomsen LL, Olesen J, et al. Coexisting typical migraine in familial hemiplegic migraine. Neurology 2010; 74: 594-600.

Iizuka T, Takahashi Y, Sato M, et al. Neurovascular changes in prolonged migraine aura in FHM with a novel ATP1A2 gene mutation. J Neurol Neurosurg Psychiat 2012; 83: 205-212.

Jurkat-Rott K, Freilinger T, Dreier JP, et al. Variability of familial hemiplegic migraine with novel A1A2 Na+/K+-ATPase variants. Neurology 2004; 62: 1857-1861.

Kirchmann M, Thomsen LL, Olesen J. Basilar-type migraine: clinical, epidemiologic, and genetic features. Neurology 2006; 66: 880-886.

Leo L, Gherardini L, Barone V, et al. Increased susceptibility to cortical spreading depression in the mouse model of familial hemiplegic migraine type 2. PloS Genet 2011; 7: e1002129.

Thomsen LL, Eriksen MK, Roemer SF, et al. A population-based study of familial hemiplegic migraine suggests revised diagnostic criteria. Brain 2002; 125: 1379-1391.

Thomsen LL, Kirchmann M, Bjornsson A, et al. The genetic spectrum of a population-based sample of familial hemiplegic migraine. Brain 2007; 130: 346-356.

Thomsen LL, Ostergaard E, Olesen J, et al. Evidence for a separate type of migraine with aura: sporadic hemiplegic migraine. Neurology 2003; 60: 595-601.

Vanmolkot KRJ, Kors EE, Turk U, et al. Two de novo mutations in the Na,K-ATPase gene ATP1A2 associated with pure familial hemiplegic migraine. Eur J Human Genet 2006; 14: 555-560.

1.2.4 Retinale Migräne

Carroll D. Retinal migraine. Headache 1970; 10: 9-13.

Chronicle EP, Mulleners WM. Visual system dysfunction in migraine: a review of clinical and psychophysical findings. Cephalalgia 1996; 16: 525-535.

Hedges TR. Isolated ophthalmic migraine in the differential diagnosis of cerebro-ocular ischemia. Stroke 1976; 7: 379-381.

Grosberg BM, Solomon S, Friedman DI, Lipton RB. Retinal migraine reappraised. Cephalalgia 2006; 26: 1275-1286.

Hill DL, Daroff RB, Ducros A, Newman NJ, Biousse V. Most cases labeled as “retinal migraine” are not migraine. J Neuroophthalmol 2007; 27: 3-8.

Martin TJ, Corbett JJ. Disorders of the eye. In Silberstein SD, Lipton RB, Dalessio DJ, editors. Wolff’s Headache and Other Head Pain. New York: Oxford University Press 2001; 459-474.

Troost T, Zagami AS. Ophthalmoplegic migraine and retinal migraine. In Olesen J, Tfelt-Hansen P, Welch KMA, editors. The Headaches. Philadelphia: Lippincott Williams & Wilkins 2000; 511-516.

1.3 Chronische Migräne

Aurora SK. Is chronic migraine one end of a spectrum of migraine or a separate entity? Cephalalgia 2009; 29: 597-605.

Bigal ME, Lipton RB. Concepts and mechanisms of migraine chronification. Headache 2008; 48: 7-15.

Bigal M, Rapoport A, Sheftell F, Tepper S, Lipton R. The International Classification of Headache Disorders revised criteria for chronic migraine – field testing in a headache specialty clinic. Cephalalgia 2007; 27: 230-234.

Bigal ME, Serrano D, Reed M, Lipton RB. Chronic migraine in the population: burden, diagnosis, and satisfaction with treatment. Neurology 2008; 71: 559-566.

Bigal ME, Sheftell FD, Rapoprt AM, Lipton RB, Tepper SJ. Chronic daily headache in a tertiary care population: correlation between the International Headache Society diagnostic criteria and proposed revisions of criteria for chronic daily headache. Cephalalgia 2002; 22: 432-438.

Bloudek LM, Stokes M, Buse DC, Wilcox TK, Lipton RB, Goadsby PJ, Varon SF, Blumenfeld AM, Katsarava Z, Pascual J, Lanteri-Minet M, Cortelli P, Martelletti P. Cost of healthcare for patients with migraine in five European countries: results from the International Burden of Migraine Study (IBMS). J Headache Pain 2012; 13: 361-378.

Buse DC, Manack AN, Fanning KM, Serrano D, Reed ML, Turkel CC, Lipton RB. Chronic migraine prevalence, disability, and sociodemographic factors. Results from the American Migraine Prevalence and Prevention Study. Headache 2012; 52: 1456-1470.

Buse D, Manack A, Serrano D, Reed M, Varon S, Turkel C, Lipton R. Headache impact of chronic and episodic migraine: results from the American Migraine Prevalence and Prevention study. Headache 2012; 52: 3-17.

Diamond S. A view of chronic daily headache. Headache Quart 2000; 11: 177.

Diener HC, Dodick DW, Goadsby PJ, Lipton RB, Olesen J, Silberstein SD. Chronic migraine – classification, characteristics and treatment. Nat Rev Neurol 2012; 8: 162-171.

Goadsby PJ, Hargreaves R. Refractory migraine and chronic migraine: pathophysiological mechanisms. Headache 2008; 48: 799-804.

Katsarava Z, Manack A, Yoon MS, Obermann M, Becker H, Dommes P, Turkel C, Lipton RB, Diener HC. Chronic migraine: classification and comparisons. Cephalalgia 2011; 31: 520-529.

Manzoni GC, Bonavita V, Bussone G, Cortelli P, Narbone MC, Cevoli S, D’Amico D, De Simone R, Torelli P; ANIRCEF (Associazione Neurologica Italiana Ricerca Cefalee). Chronic migraine classification: current knowledge and future perspectives. J. Headache Pain 2001; 12: 585-592.

Mathew NT, Stubits E, Nigam MR. Transformation of migraine into daily headache: analysis of factors. Headache 1982; 22: 66-68.

Mathew NT, Stubits E, Nigam MP. Transformed or evolutive migraine. Headache 1987; 27: 102-106.
Natoli JL, Manack A, Dean B, Butler Q, Turkel CC, Stovner L, Lipton RB. Global prevalence of chronic migraine: a systematic review. Cephalalgia 2010; 30: 599-609.

Scher AI, Stewart WF, Liberman J, Lipton RB. Prevalence of frequent headache in a population sample. Headache 1998; 38: 497-506.

Scher AI, Stewart WF, Ricci JA, Lipton RB. Factors associated with the onset and remission of chronic daily headache in a population-based study. Pain 2003; 106: 81-89.

Silberstein SD, Lipton RB, Sliwinski M. Classification of daily and near-daily headaches: field trial of revised IHS criteria. Neurology 1996; 47: 871-875.

Silberstein SD, Lipton RB, Solomon S, Mathew NT. Classification of daily and near-daily headaches: proposed revisions to the IHS criteria. Headache 1994; 34: 1-7.

Stewart WF, Scher AI, Lipton RB. Stressful life events and risk of chronic daily headache: results from the frequent headache epidemiology study. Cephalalgia 2001; 21: 279.

Yalın OÖ, Uluduz D, Özge A, Sungur MA, Selekler M, Siva A. Phenotypic features of chronic migraine. J Headache Pain 2016; 17: 26.

Zeeberg P, Olesen J, Jensen R. Probable medication-overuse headache: the effect of a 2-month drug-free period. Neurology 2006; 66: 1894-1898.

Zeeberg P, Olesen J, Jensen R. Medication overuse headache and chronic migraine in a specialized headache centre: field-testing proposed new Anhang criteria. Cephalalgia 2009; 29: 214-220.

1.4.1 Status migränosus

Akhtar ND, Murray MA, Rothner AD. Status migrainosus in children and adolescents. Semin Pediatr Neurol 2001; 8: 27-33.

Beltramone M, Donnet A. Status migrainosus and migraine aura status in a French tertiary-care center: An 11-year retrospective analysis. Cephalalgia 2014; 34: 633-637.

Couch JR, Diamond S. Status migrainosus. Causative and therapeutic aspects. Headache 1983; 23: 94-101.

Cure J, Rothrock J. Prolonged status migrainosus complicated by cerebellar infarction. Headache 2007; 47: 1091-1092.

Gentile S, Rainero I, Daniele D, Binello E, Valfrè W, Pinessi L. Reversible MRI abnormalities in a patient with recurrent status migrainosus. Cephalalgia 2009; 29: 687-690.

Lanfranconi S, Corti S, Bersano A, Costa A, Prelle A, Sciacco M, Bresolin N, Ghione I. Aphasic and visual aura with increased vasogenic leakage: an atypical migrainosus status. J Neurol Sci 2009; 285: 227-229.

Perucca P, Terzaghi M, Manni R. Status epilepticus migrainosus: clinical, electrophysiologic, and imaging characteristics. Neurology 2010; 75: 373-374.

Raskin NH. Treatment of status migrainosus: the American experience. Headache 1990; 30 Suppl 2: 550-553.

1.4.2 Anhaltende Aura ohne Hirninfarkt

Ambrosini A, de Noordhout AM, Schoenen J. Neuromuscular transmission in migraine patients with prolonged aura. Acta Neurol Belg 2001; 101: 166-170.

Bento MS, Esperanca P. Migraine with prolonged aura. Headache 2000; 40: 52-53.

Chen WT, Fuh JL, Lu SR, Wang SJ. Persistent migrainous visual phenomena might be responsive to lamotrigine. Headache 2001; 41: 823-825.

Chen WT, Lin YY, Fuh JL, Hämäläinen MS, Ko YC, Wang SJ. Sustained visual cortex hyperexcitability in migraine with persistent visual aura. Brain 2011; 134 (Pt 8): 2387-2395.

Evans RW, Lay CL. A persistent migraine aura. Headache 2000; 40: 696-698.

Haan J, Sluis P, Sluis IH, Ferrari MD. Acetazolamide treatment for migraine aura status. Neurology 2000; 55: 1588-1589.

Haas DC. Prolonged migraine aura status. Ann Neurol 1982; 11: 197-199.

Lebedeva ER, Gurary NM, Gilev DV, Olesen J. Prospective testing of ICHD-3 beta diagnostic criteria for migraine with aura and migraine with typical aura in patients with transient ischemic attacks. Cephalalgia 2018; 38: 561-567.

Liu GT, Schatz NJ, Galetta SK et al. Persistent positive visual phenomena in migraine. Neurology 1995; 45: 664-668.

Luda E, Bo E, Sicuro L et al. Sustained visual aura: a totally new variation of migraine. Headache 1991; 31: 582-583.

Relja G, Granato A, Ukmar M, Ferretti G, Antonello RM, Zorzon M. Persistent aura without infarction: decription of the first case studied with both brain SPECT and perfusion MRI. Cephalalgia 2005; 25: 56-59.

Rothrock JF. Successful treatment of persistent migraine aura with divalproex sodium. Neurology 1997; 48: 261-262.

San-Juan OD, Zermeño PF. Migraine with persistent aura in a Mexican patient: case report and review of the literature. Cephalalgia 2007; 27: 456-460.

Smith M, Cros D, Sheen V. Hyperperfusion with vasogenic leakage by fMRI in migraine with prolonged aura. Neurology 2002; 58: 1308-1310.

Wang YF, Fuh JL, Chen WT, Wang SJ. The visual aura rating scale as an outcome predictor for persistent visual aura without infarction. Cephalalgia 2008; 28: 1298-1304.

1.4.3 Migränöser Infarkt

Bono G, Minonzio G, Mauri M, Clerici AM. Complications of migraine: migrainous infarction. Clin Exp Hypertens 2006; 28: 233-242.

Bousser MG, Conard J, Kittner S et al. Recommendations on the risk of ischemic stroke associated with use of combined oral contraceptives and hormone replacement therapy in women with migraine. The International Headache Society Task Force on Combined Oral Contraceptives & Hormone Replacement Therapy. Cephalalgia 2000; 20: 155-156.

Chang CL, Donaghy M, Poulter N. Migraine and stroke in young women: case-control study. The World Health Organization Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception. BMJ 1999; 318: 13-18.

Connor CCR. Complicated migraine. A study of permanent neurological and visual defects. Lancet 1962; ii: 1072-1075.

Laurell K, Artto V, Bendtsen L, Hagen K, Kallela M, Meyer EL, Putaala J, Tronvik E, Zwart JA, Linde M. Migrainous infarction: a Nordic multicenter study. Eur J Neurol 2011; 18: 1220-1226.

MacGregor EA, Guillebaud J. Combined oral contraceptives, migraine and ischemic stroke. Clinical and Scientific Committee of the Faculty of Family Planning and Reproductive Health Care and the Family Planning Association. Br J Fam Plann 1998; 24: 55-60.

Olesen J, Friberg L, Olsen TS, Andersen AR, Lassen NA, Hansen PE et al. Ischaemia-induced (symptomatic) migraine attacks may be more frequent than migraine induced ischemic insults. Brain 1993; 116: 187-202.

Rothrock JF, Walicke P, Swenson MR et al. Migrainous stroke. Arch Neurol 1988; 45: 63-67.

Schulz UG, Blamire AM, Davies P, Styles P, Rothwell PM. Normal cortical energy metabolism in migrainous stroke: A 31P-MR spectroscopy study. Stroke. 2009; 40: 3740-3744.

Tietjen GE. The relationship of migraine and stroke. Neuroepidemiology 2000; 19: 13-19.

Tzourio C, Kittner SJ, Bousser MG et al. Migraine and stroke in young women. Cephalalgia 2000; 20: 190-199.

Vollbracht S, Robbins MS, Kister I. Classification challenge in migrainous infarction. Headache 2014; 54: 170-171.

Wolf ME, Szabo K, Griebe M, Förster A, Gass A, Hennerici MG, Kern R. Clinical and MRI characteristics of acute migrainous infarction. Neurology 2011; 76: 1911-1917.

1.4.4 Epileptische Anfälle, durch Migräneaura getriggert

Belcastro V, Striano P, Kasteleijn-Nolst Trenité DG, Villa MP, Parisi P. Migralepsy, hemicrania epileptica, post-ictal headache and “iktaler Kopfschmerz bei Epilepsie”: a proposal for terminology and classification revision. J Headache Pain 2011; 12: 289-294.

Davies PT, Panayiotopoulos CP. Migraine triggered seizures and epilepsy triggered headache and migraine attacks: a need for re-assessment. J Headache Pain 2011; 12: 287-288.

Friedenberg S, Dodick DW. Migraine-associated seizure: a case of reversible MRI abnormalities and persistent nondominant hemisphere syndrome. Headache 2000; 40: 487-490.

Maggioni F, Mampreso E, Ruffatti S, Viaro F, Lunardelli V, Zanchin G. Migralepsy: is the current definion too narrow? Headache 2008; 48: 1129-1132.

Marks DA, Ehrenberg BL. Migraine-related seizures in adults with epilepsy, with EEG correlation. Neurology 1993; 43: 2476-2483.

Merlino G, Valente MR, D’Anna S, Gigli GL. Seizures with prolonged EEG abnormalities during an attack of migraine without aura. Headache 2007; 47: 919-922.

Parisi P, Kasteleijn-Nolst Trenitè DGA. “Migralepsy”: a call for revision of the definition. Epilepsia 2010; 51: 932-933.

Rogawski MA. Common pathophysiologic mechanisms in migraine and epilepsy. Arch Neurol 2008; 65: 709-714.

Sances G, Guaschino E, Perucca P, Allena M, Ghiotto N, Manni R. Migralepsy: a call for revision of the definition. Epilepsia 2009; 50: 2487-2496.

Ter Berg HW. Migraine-associated seizure: a case of reversible MRI abnormalities and persistent nondominant hemisphere syndrome. Headache 2001; 41: 326-328.

Velioglu SK, Ozmenoglu M. Migraine-related seizures in an epileptic population. Cephalalgia 1999; 19: 797-801.

Verrotti A, Coppola G, Di Fonzo A, Tozzi E, Spalice A, Aloisi P, Bruschi R, Iannetti P, Villa MP, Parisi P. Should “migralepsy” be considered an obsolete concept? A multicenter retrospective clinical/EEG study and review of the literature. Epilepsy Behav 2011; 21: 52-59.

1.5 Wahrscheinliche Migräne

Granella F, Alessandro RD, Manzoni GC et al. International Headache Society classification: interobserver reliability in the diagnosis of primary headaches. Cephalalgia 1994; 14: 16-20.

Rains JC, Penzien DB, Lipchik GL et al. Diagnosis of migraine: empirical analysis of a large clinical sample of atypical migraine (IHS 1.7) patients and proposed revision of the IHS criteria. Cephalalgia 2001, 21: 584-595.

Rasmussen BK, Jensen R, Olesen J. A population-based analysis of the diagnostic criteria of the International Headache Society. Cephalalgia 1991; 11: 129-134.

Russell MB, Olesen J. Migrainous disorder and its relation to migraine without aura and migraine with aura. A genetic epidemiological study. Cephalalgia 1996; 16: 431-435.

1.6.1 Rezidivierende gastrointestinale Störungen

Abu-Arafeh I, Russel G. Prevalence and clinical features of abdominal migraine compared with those of migraine headache. Arch Dis Child 1995; 72: 413-417.

Al-Twaijri WA, Shevell MI. Pediatric migraine equivalents: occurrence and clinical features in practice. Pediatr Neurol 2002; 26: 365-368.

Dignan F, Abu-Arafeh I, Russell G. The prognosis of childhood abdominal migraine. Arch Dis Child 2001; 84: 415-418.

Drossman DA, Dumitrascu DL. Rome III: New standard for functional gastrointestinal disorders. J Gastrointestin Liver Dis 2006; 15: 237-241.

Farquar HA. Abdominal migraine in children. BMJ 1956; i: 1082-1085.

Fleisher DR. Cyclic vomiting syndrome and migraine. J Pediatr 1999; 134: 533-535.

Haan J, Kors EE, Ferrari MD. Familial cyclic vomiting syndrome. Cephalalgia 2002; 22: 552-554.

Li BU. Cyclic vomiting syndrome: age-old syndrome and new insights. Semin Pediatr Neurol 2001; 8: 13-21.

Li BUK, Lefevre F, Chelimsky GG, Boles RG, Nelson SP, Lewis DW, Linder SL, Issenman RM, Rudolph CD. NASPGHAN Consensus Statement on the Diagnosis and Management of CVS. J Pediatr Gastroenterol Nutr 2008; 47: 379-393.

Rashed H, Abell TL, Familoni BO et al. Autonomic function in cyclic vomiting syndrome and classic migraine. Dig Dis Sci 1999; 44 Suppl 8: 74S-78S.

Russell G, Abu-Arafeh I, Symon DN. Abdominal migraine: evidence for existence and treatment options. Paediatr Drugs 2002; 4: 1-8.

Thiessen PN. Recurrent abdominal pain. Pediatr Rev 2002; 23: 39-46.

Welch KM. Scientific basis of migraine: speculation on the relationship to cyclic vomiting. Dig Dis Sci 1999; 44 Suppl 8: 26S-30S.

1.6.2 Gutartiger paroxysmaler Schwindel

Drigo P, Carli G, Laverda AM. Benign paroxysmal vertigo of childhood. Brain Dev (Netherlands) 2001; 23: 38-41.

Dunn DW, Snyder CH. Benign paroxysmal vertigo of childhood. Am J Dis Child 1976; 130: 1099-1100.
Fenichel GM. Migraine as a cause of benign paroxysmal vertigo of childhood. J Pediatr 1967; 71: 114-115.

1.6.3 Gutartiger paroxysmaler Torticollis

Drigo, P., G. Carli, et al. Benign paroxysmal torticollis of infancy. Brain Dev 2000; 22: 169-172.

Giffin NJ, Benton S, et al. Benign paroxysmal torticollis of infancy: four new cases and linkage to CACNA1A mutation. Dev Med Child Neurol 2002; 44: 490-493.

Rosman NP, Douglass LM, et al. The neurology of benign paroxysmal torticollis of infancy: report of 10 new cases and review of the literature. J Child Neurol 2009; 24: 155-160.